Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis

被引:9
作者
Liu, Weicen [1 ]
Ren, Jun [1 ]
Zhang, Jinlong [1 ]
Song, Xiaohong [1 ]
Liu, Shuling [1 ]
Chi, Xiangyang [1 ]
Chen, Yi [1 ]
Wen, Zhonghua [1 ]
Li, Jianmin [1 ]
Chen, Wei [1 ]
机构
[1] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China
来源
PLOS ONE | 2017年 / 12卷 / 05期
基金
中国国家自然科学基金;
关键词
CAPSULAR ANTIGEN; VACCINE; PURIFICATION; EFFICACY; STRAIN; VIRUS;
D O I
10.1371/journal.pone.0177012
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Yersinia pestis (Y. pestis) has caused an alarming number of deaths throughout recorded human history, and novel prophylactics and therapeutics are necessary given its potential as a bioweapon. Only one monoclonal antibody has been identified to date that provides complete protection against Y. pestis. Here, we describe a second novel murine monoclonal antibody (F2H5) that provided complete protection against Y. pestis 141 infection when administered prophylactically to Balb/c mice (100 mu g intravenously). We humanized F2H5, characterized its ability to bind to the Y. pestis F1 protein and further characterized the neutralizing epitope using computational and experimental approaches. While Western blot results suggested a linear epitope, peptide mapping using ELISA failed to identify an epitope, suggesting a conformational epitope instead. We adopted a computational approach based on Residue Contact Frequency to predict the site of antigen-antibody interaction and defined the F2H5/F1 binding site computationally. Based on computational approach, we determined that residues G(104)E(105)N(106) in F1 were critical to F2H5 binding and that CDRH2 and CDRH3 of F2H5 interacted with F1. Our results show that combining computational approach and experimental approach can effectively identify epitopes.
引用
收藏
页数:17
相关论文
共 27 条
[21]   Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency [J].
Tharakaraman, Kannan ;
Robinson, Luke N. ;
Hatas, Andrew ;
Chen, Yi-Ling ;
Liu Siyue ;
Raguram, S. ;
Sasisekharan, V. ;
Wogan, Gerald N. ;
Sasisekharan, Ram .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (17) :E1555-E1564
[22]  
Vorontsov E D, 1990, Biomed Sci, V1, P391
[23]   Updates to the Integrated Protein-Protein Interaction Benchmarks: Docking Benchmark Version 5 and Affinity Benchmark Version 2 [J].
Vreven, Thom ;
Moal, Iain H. ;
Vangone, Anna ;
Pierce, Brian G. ;
Kastritis, Panagiotis L. ;
Torchala, Mieczyslaw ;
Chaleil, Raphael ;
Jimenez-Garcia, Brian ;
Bates, Paul A. ;
Fernandez-Recio, Juan ;
Bonvin, Alexandre M. J. J. ;
Weng, Zhiping .
JOURNAL OF MOLECULAR BIOLOGY, 2015, 427 (19) :3031-3041
[24]   A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge [J].
Wang, Tang ;
Qi, Zhizhen ;
Wu, Benchuan ;
Zhu, Ziwen ;
Yang, Yonghai ;
Cui, Baizhong ;
Dai, Ruixia ;
Zhang, Qingwen ;
Qiu, Yefeng ;
Wang, Zuyun ;
Wang, Hu ;
Guo, Zhaobiao ;
Wang, Xiaoyi ;
Yang, Ruifu .
PROTEIN EXPRESSION AND PURIFICATION, 2008, 61 (01) :7-12
[25]   Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model [J].
Xiao, Xiaodong ;
Zhu, Zhongyu ;
Dankmeyer, Jennifer L. ;
Wormald, Michael M. ;
Fast, Randy L. ;
Worsham, Patricia L. ;
Cote, Christopher K. ;
Amemiya, Kei ;
Dimitrov, Dimiter S. .
PLOS ONE, 2010, 5 (10)
[26]  
Xu Jun-jie, 2005, Weishengwu Xuebao, V45, P947
[27]  
Zhang J, 2013, PROCEEDINGS OF THE 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE FOR ENGINEERING SOLUTIONS (CIES), P29, DOI 10.1109/CIES.2013.6611725